Orphazyme down to 20 employees after multiple firing rounds

Biotech company Orphazyme has cut staff numbers to around 20, down from 180 last summer, according to Deputy Chair Bo Jesper Hansen.

The negative events of the past year involving Orphazyme have not just made their mark on the biotech company’s finances, but also on its number of staff.

Orphazyme, which released its restructuring plan last Thursday, has been forced to reduce its employee headcount several times this year, most recently in connection with the start of the reconstruction efforts in mid March. At that time, it was announced that 50 percent of the global company workforce would be laid off.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs